Literature DB >> 2212862

Use of ektacytometry to determine red cell susceptibility to oxidative stress.

F A Kuypers1, M D Scott, M A Schott, B Lubin, D T Chiu.   

Abstract

To define a more sensitive and reliable method to determine changes in the overall cellular characteristics of erythrocytes after oxidative damage, we used a viscodiffractometric method (ektacytometry) to measure the effect of oxidative stress. Erythrocytes were incubated in the presence of hydrogen peroxide, t-butyl hydroperoxide, or cumene hydroperoxide in phosphate buffer. This treatment resulted in decreased cellular deformability of the intact erythrocytes. In addition, deformability and fragility measurements of the erythrocyte ghost membranes indicated an increased membrane dynamic rigidity and altered-mechanical stability as a consequence of oxidant stress. These changes were observed before the onset of hemolysis. The observed decrease in deformability was accompanied by oxidation of hemoglobin, alterations of membrane proteins, and lipid peroxidation. To continuously measure the time course of the decrease in deformability in intact erythrocytes under oxidative stress, a new ektacytometric method was developed. Erythrocytes were oxidatively challenged within the viscometer at a constant osmolality and shear stress. The change in deformability was monitored and a typical range was defined for erythrocytes from normal individuals. Comparison of erythrocytes from patients with sickle cell disease with those from normal individuals demonstrated a higher susceptibility of sickle red cells toward oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212862

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  14 in total

Review 1.  Biomechanical properties of red blood cells in health and disease towards microfluidics.

Authors:  Giovanna Tomaiuolo
Journal:  Biomicrofluidics       Date:  2014-09-17       Impact factor: 2.800

2.  Vincristine-induced anemia in hereditary spherocytosis.

Authors:  Jennifer Michlitsch; Sandra Larkin; Elliott Vichinsky; Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-04

3.  A pilot study of subcutaneous decitabine in β-thalassemia intermedia.

Authors:  Nancy F Olivieri; Yogen Saunthararajah; Vivek Thayalasuthan; Janet Kwiatkowski; Russell E Ware; Frans A Kuypers; Hae-Young Kim; Felicia L Trachtenberg; Elliott P Vichinsky
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

4.  Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes.

Authors:  Tennille D Presley; Andreas S Perlegas; Lauren E Bain; Samir K Ballas; James S Nichols; Hernan Sabio; Mark T Gladwin; Gregory J Kato; Daniel B Kim-Shapiro
Journal:  Hemoglobin       Date:  2010       Impact factor: 0.849

Review 5.  Altered phosphorylation of cytoskeleton proteins in sickle red blood cells: the role of protein kinase C, Rac GTPases, and reactive oxygen species.

Authors:  Alex George; Suvarnamala Pushkaran; Lina Li; Xiuli An; Yi Zheng; Narla Mohandas; Clinton H Joiner; Theodosia A Kalfa
Journal:  Blood Cells Mol Dis       Date:  2010-03-15       Impact factor: 3.039

6.  Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo.

Authors:  Madhan Thamilarasan; Rodolfo Estupinan; Ines Batinic-Haberle; Rahima Zennadi
Journal:  Blood Adv       Date:  2020-06-09

7.  Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells.

Authors:  Sylvia T Singer; Elliott P Vichinsky; Sandra Larkin; Nancy Olivieri; Nancy Sweeters; Frans A Kuypers
Journal:  Am J Hematol       Date:  2008-11       Impact factor: 10.047

8.  Deformability analysis of sickle blood using ektacytometry.

Authors:  Miklos Rabai; Jon A Detterich; Rosalinda B Wenby; Tatiana M Hernandez; Kalman Toth; Herbert J Meiselman; John C Wood
Journal:  Biorheology       Date:  2014       Impact factor: 1.875

9.  Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation.

Authors:  Marcel H Fens; Pedro Cabrales; Jan Scicinski; Sandra K Larkin; Jung H Suh; Frans A Kuypers; Neil Oronsky; Michelle Lybeck; Arnold Oronsky; Bryan Oronsky
Journal:  Med Oncol       Date:  2016-07-04       Impact factor: 3.064

10.  Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant.

Authors:  J S Friedman; V I Rebel; R Derby; K Bell; T T Huang; F A Kuypers; C J Epstein; S J Burakoff
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.